CompletedNot Applicable

Effect of a CKD Dashboard on Patient Activation and Shared Decision Making

Netherlands150 participantsStarted 2021-01-04

Plain-language summary

The goal of this clinical pre-post study is to evaluate the effect of using a CKD dashboard, which visualizes individual patient data in patients with Chronic Kidney Disease stage 3b-4, and is used to structure the conversation during patient-clinician health visits. The main question\[s\] it aims to answer are: • what is the effect of the dashboard on patient activation levels (or outcomes related to patient activation)? • What is the effect of the dashboard on the conversation during health visits, including Shared Decision Making (SDM), Motivational interviewing (MI) and conversation topics? Participants will receive three surveys and have two routine care follow up consultations with their clinician audio recorded. Researchers will compare the same patients before and after implementation as well as compare them with patients in another hospital where no dashboard is (yet) implemented to see if patient activation levels (and related outcomes) increase, and whether there is an increase in SDM, MI and a difference in conversation topics.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients will be eligible for participations if they meet all the following criteria: * Patients with Chronic Kidney Disease in stages G3b until G4 due to all causes * Patients are treated for chronic kidney disease in the participating hospitals * ≥ 18 years of age * Be able to understand Dutch language in speech and writing or have someone assist them in understanding Dutch language. * Able to provide informed consent Exclusion Criteria: * Patients with dementia or severe cognitive impairment are excluded from this study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Patient Activation Measure

Timeframe: Change from baseline (pre-implementation dashboard) to the following consultation more than 3 months later (post-implementation dashboard)

Patient Activation Measure

Timeframe: Change from baseline (pre-implementation dashboard) to one year after implementation of the dashboard.

Trial details

NCT IDNCT05931978

SponsorSt. Antonius Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-14

View on ClinicalTrials.gov More Chronic Kidney Disease Stage 3B trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Patient Activation Measure

Timeframe: Change from baseline (pre-implementation dashboard) to the following consultation more than 3 months later (post-implementation dashboard)

Patient Activation Measure

Timeframe: Change from baseline (pre-implementation dashboard) to one year after implementation of the dashboard.